Gabelli & Co Investment Advisers’s Axonics, Inc. Common Stock AXNX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-257,293	Closed	-$17.9M	–	288
2024 Q3	$17.9M	Buy	257,293 +41,143	+19%	+$2.82M	3.05%	6
2024 Q2	$14.5M	Buy	216,150 +84,450	+64%	+$5.69M	2.43%	10
2024 Q1	$9.08M	Buy	+131,700	New	+$8.89M	1.58%	17

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gabelli & Co Investment Advisers's AXNX Position: Q4 2024 in Review

Gabelli & Co Investment Advisers sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 257,293 shares — an estimated $17.9M sold.

Gabelli & Co Investment Advisers first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $17.9M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Gabelli & Co Investment Advisers reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 257,293 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $17.9M.
Gabelli & Co Investment Advisers first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Gabelli & Co Investment Advisers's Axonics, Inc. Common Stock position peaked at $17.9M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2024, filed 13 Feb 2025.